Abstract: The present invention provides for a composition and method of treatment and prevention of hypertension and its restulting complication comprising the step of administering to a patient a therapeutically-effective amount of Quercetin or Quercetin Glycoside and Epican Forte in therapeutic proportions.

Abstract: A composition of L-ascorbic acid derivatives is described comprising L-ascorbic acid and lysine or lysine moieties, wherein L-ascorbic acid is covalently bound to the lysine or lysine moieties. The composition so described is used to prevent the degradation of extracellular matrix, stabilize connective tissue, is used to as an antioxident, and is used for treating damage to skin comprising applying the topical composition to the skin.

Abstract: A circuit producing a reversed bandgap reference voltage circuit VRBG includes first and second resistors coupled as a voltage divider between ground and a first conductor, a base of a first transistor being coupled to the voltage divider to produce a first voltage VBE1(1+1/M) between the first conductor and ground, M being a ratio of the resistances of the first and second resistors. A third resistor is coupled between a base of the second transistor and ground to produce a second voltage VBE2+VRBGP between the second conductor and ground. First circuitry forces the collector current of the first transistor to be equal to the collector current of the second transistor, and second circuitry forces the first voltage VBE1(1+1/M) to be equal the second voltage VBE2+VRBGP. One of the first circuitry and second circuitry includes an operational amplifier coupled to effectuate the forcing.

Abstract: The present invention provides a nutritional composition effective in facilitating bone healing in human, comprising lysine, proline, ascorbic acid, copper, vitamin B6. The nutritional composition contains 27-34% wt lysine, 14-16% wt proline, and 42-47% wt ascorbic acid. The nutritional composition further comprises vitamin A, vitamin D3, vitamin E, vitamin B1, vitamin B2, niacin, folic acid, vitamin B12, biotin, pantothenic acid, calcium, phosphorus, magnesium, zinc, selenium, manganese, chromium, molybdenum, potassium, citrus fruit peel bioflavanoids, arginine, cysteine, inositol, carnitine, coenzyme Q10, and pycnogenol. The present invention also relates to uses of the nutritional composition in human for facilitating bone healing.

Abstract: An operational amplifier includes an input stage for producing a a voltage signal in response to an input signal. An output stage includes an output transistor having a source coupled to a supply voltage and a gate coupled to receive the voltage signal. An output cascode transistor has a source coupled to a drain of the output transistor and a drain coupled to an output conductor. A gate control amplifier includes an input stage including a first input transistor having a control electrode coupled to the source of the output cascode transistor and an active load transistor, the input transistor and the active load transistor being coupled to a gate of the output cascode transistor. The gate control amplifier also includes a feedback amplifier having an input coupled to the source of the output cascode transistor and an output coupled to a control electrode of the active load transistor.

Abstract: The present invention provides for a method of using a nutritional composition in inhibiting smooth muscle cell contraction, and hence lowering hypertension.

Abstract: The present invention relates to a composition comprising a catechin compound, ascorbic acid, proline and lysine. The present invention also relates to a method for treating neoplastic disease using a composition comprising a catechin compound, ascorbic acid, proline and lysine.

Abstract: A class-AB output stage circuit is configured with controllable reference voltages for providing stable quiescent current. An exemplary output stage circuit comprises one or more control circuits, such as feedback loops, configured to control and/or adjust the reference voltages within the class-AB circuit based on the output voltage and/or supply rail voltage levels. In addition, an exemplary output stage circuit can also comprise one or more clamp circuits configured to facilitate operation of the output stage circuit when the output supply is proximate to or exceeds a positive or a negative supply rail.

Abstract: The present invention relates to a composition comprising a catechin compound, ascorbic acid, proline and lysine. The present invention also relates to a method for treating neoplastic disease using a composition comprising a catechin compound, ascorbic acid, proline and lysine.

Abstract: The present invention provides a nutritional composition effective in faciliating bone healing in human, comprising lysine, proline, ascorbic acid, copper, vitamin B6. The nutritional composition contains 27-34% wt lysine, 14-16% wt proline, and 42-47% wt ascorbic acid. The nutritional composition further comprises vitamin A, vitamin D3, vitamin E, vitamin B1, vitamin B2, niacin, folic acid, vitamin B12, biotin, pantothenic acid, calcium, phosphorus, magnesium, zinc, selenium, manganese, chromium, molybdenum, potassium, citrus fruit peel bioflavanoids, arginine, cysteine, inositol, carnitine, coenzyme Q10, and pycnogenol. The present invention also provides a method of administering the nutritional composition in human effective in facilitating bone healing.

Abstract: The present invention provides pharmaceutical compositions for alleviating pathological conditions in a post-menopausal woman, comprising lysine, proline, arginine, vitamin C, magnesium, green tea extract, N-acetyl-cysteine, selenium, copper, manganese and one pharmaceutical acceptable component selected from the group consisting of a carrier, a diluent, and an excipient, wherein the pharmaceutical composition without the acceptable component contains 7-9 wt % magnesium, 20-30 wt % ascorbic acid and 11-25 wt % green tea extract. A method of treatment using the pharmaceutical compositions are also disclosed.

Abstract: A composition of L-ascorbic acid derivatives is described comprising L-ascorbic acid and lysine or lysine moieties, wherein L-ascorbic acid is covalently bound to the lysine or lysine moieties. The composition so described is used to prevent the degradation of extracellular matrix, stabilize connective tissue, is used to as an antioxidant, and is used for treating damage to skin comprising applying the topical composition to the skin.

Abstract: A class AB output circuit includes a P-channel pullup transistor (M13) having a source coupled to a supply voltage, a drain coupled to an output(10), a gate coupled to respond to an input signal on an input(9), an N-channel pulldown transistor (M1) having a drain coupled to the output, a source coupled to ground, and a gate coupled to respond to the input signal. A first N-channel transistor (M2) has a drain coupled to a gate of the output transistor and the supply voltage by means of a current source (8) and a source coupled to ground by means of a second current source (13). A first diode-connected N-channel transistor (M3), a second diode-connected N-channel transistor (M4), and a first level shifting circuit (17) are coupled in series between ground and a gate of the N-channel transistor, and a current source (7) is coupled between the first supply voltage and the gate of the first N-channel transistor.

Abstract: The present invention relates to a composition comprising a catechin compound, ascorbic acid, proline and lysine. The present invention also relates to a method for treating neoplastic disease using a composition comprising a catechin compound, ascorbic acid, proline and lysine.

Abstract: The present invention provides for a method of using a nutritional composition in inhibiting smooth muscle cell contraction, and hence lowering hypertension.

Abstract: The present invention provides pharmaceutical compositions for alleviating pathological conditions in a post-menopausal woman, comprising lysine, proline, arginine, ascorbic acid, magnesium, green tea extract, N-acetyl-cysteine, selenium, copper, manganese and one pharmaceutical acceptable component selected from the group consisting of a carrier, a diluent, and an excipient, wherein the compositions contain 24-25 wt % lysine, 16-25 wt % ascorbic acid and 22-25 wt % green tea extract. A method of treatment using the pharmaceutical compositions are also disclosed.

Abstract: The present invention provides for a composition and method of treatment and prevention of hypertension and its resulting complications comprising the step of administering to a patient a therapeutically-effective amount of Quercetin or Quercetin Glycoside and Epican Forte in therapeutic proportions.

Abstract: A composition of L-ascorbic acid derivatives is described comprising L-ascorbic acid and lysine or lysine moieties, wherein L-ascorbic acid is covalently bound to the lysine or lysine moieties. The composition so described is used to prevent the degradation of extracellular matrix, stabilize connective tissue, is used to as an antioxident, and is used for treating damage to skin comprising applying the topical composition to the skin.

Abstract: A modulation scheme can drive an associated load that is coupled between a pair of outputs by providing a switching signal at one of the outputs and a non-switching signal at the other output independent of the direction of current relative to the respective outputs. Because switching occurs only at one of the outputs in this mode of operation, a single filter can be used to mitigate switching noise at the switching output. Another aspect relates to another mode of operation in which one or both of the outputs can be controlled to operate linearly, such as during a zero crossing condition, so as to help reduce crossover distortion.

Abstract: A modulation scheme can drive an associated load that is coupled between a pair of outputs by providing a switching signal at one of the outputs and a non-switching signal at the other output independent of the direction of current relative to the respective outputs. Because switching occurs only at one of the outputs in this mode of operation, a single filter can be used to mitigate switching noise at the switching output. Another aspect relates to another mode of operation in which one or both of the outputs can be controlled to operate linearly, such as during a zero crossing condition, so as to help reduce crossover distortion.